retatrutide phase 2 trial dose escalation schedule Eli Lilly just announced striking 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Triple hormone receptor agonist retatrutide

She was previously part of the team appointed co-lead counsel in the landmark 3M Combat Arms Earplug Products Liability Litigation , the largest mass tort in American history

veterans with type 2 diabetes taking the drugs showed that halting or interrupting treatment was linked to a significant increase in the risk of major cardiovascular events

When you speed up the production of new blood cells with blood donation, it means your A1C is measuring the amount of glucose attached to younger cells

As of early 2026, the most effective GLP-1 drug for weight loss is tirzepatide (Mounjaro, Zepbound)

In recent years, GLP-1RAs have become a focal point in the medical community due to their innovative treatment mechanisms, robust therapeutic efficacy, and expansive development prospects